Christina Boull, MD, explains how pediatricians can recognize dermatologic conditions in darker skin tones and address pigment changes and treatment gaps.
News|Articles|December 26, 2025
Top 5 dermatology Puzzler case studies of 2025
Author(s)Joshua Fitch, Senior Editor
Fact checked by: Contemporary Pediatrics Staff, Justin Mancini
Join us for a recap of some of our top dermatology Puzzler cases from 2025.
Advertisement
Advertisement
Welcome to another edition of Countdown to 2026, and thank you for visiting and following Contemporary Pediatrics throughout 2025. In this edition, we present our top dermatology case studies published this year.
Related to this article
Christina Boull, MD, shares recommendations for infant skin care, including choosing gentle cleansers, avoiding irritants, and supporting the skin barrier.
Topical botanical Cinainu earned FDA Breakthrough Therapy status for AA in patients aged 2+, supported by phase 2/3 RAAINBOW data in children.
A teen’s track collapse reveals CPVT, a hidden inherited arrhythmia; rapid CPR/AED response and family cascade screening prevent sudden cardiac arrest across generations.
Real-world claims show dupilumab was tied to a 33%-52% lower risk of atopic march progression vs systemic corticosteroids in children with AD.
Once-daily roflumilast cream 0.05% was well tolerated in infants 3 to <24 months with AD, with 34.4% reaching vIGA-AD success at week 4.
Oral icotrokinra kept PASI 90 rates at ≥72% and IGA 0/1 at ≥70% from week 64 to 112 in ICONIC-LEAD, with no new safety signals.
At AAP 2026, Peter Lio, MD, discussed distinguishing allergic and inflammatory skin conditions and when pediatricians should seek specialty care.
Advertisement
Advertisement